Dr. Rocklage is the Managing Partner of 5AM Ventures Management LLC, a venture capital firm which focuses on life-sciences. Dr. Rocklage became the Managing Partner of 5AM Ventures Management LLC in 2004 after serving as a Venture Partner with the organization in 2003. 5AM Ventures provides investments to corporations in the early stages of their organizations. Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift
Scott Rocklage has demonstrated a life-long commitment to scientific endeavors. Dr. Rocklage has over thirty years of healthcare management experience. He is the former President and CEO of Nycomed Salutar. Dr. Rocklage earned a Bachelor of Science degree in Chemistry from California Berkley. Read more: Sccot Racklage | Bloomberg and Scott Racklage | Crunchbase
Moreover, Dr. Rocklage earned a PhD from Massachusetts Institute of Technology where he conducted research under the direction of Richard R. Schrock, the 2005 Nobel Peace Prize winner in the field of Chemistry.
Dr. Rocklage is recognized as a business leader. Multiple corporations receive insight from Dr. Rocklage through his participation on various boards within corporations. Dr. Rocklage holds multiple Board of Directors positions and serves on Board of Associates in corporations.
Additionally, Dr. Rocklage is currently the Chairman of the Board of multiple businesses which include: Cidara Therapeutics Inc., Rennovia, and Kinnestral. Additionally, he served as the former Chairman of the Board of Relypsa Inc. and Novira Therapeutics Inc.
Dr. Rocklage is recognized as a research authority in his field. He is credited with numerous collaborative and individual scientific endeavors. Dr. Rocklage’s writing accomplishments include over 100 peer-reviewed publications. As an inventor, Dr. Rocklage has also invented or co-invented numerous inventions and he is credited with 30 patents.